Skip to content

Clinical Significance of Assesment of Serum miRNA-30a in Childhood Nephrotic Syndrome

Clinical Significance of Assesment of Serum miRNA-30a in Childhood Nephrotic Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03235128
Enrollment
50
Registered
2017-08-01
Start date
2017-10-01
Completion date
2019-10-01
Last updated
2017-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrotic Syndrome Steroid-Resistant

Brief summary

Childhood nephrotic syndrome is the most frequent glomerular disease that presents during childhood,primarily owing to a disturbed immune function.This disease is characterized by alterations in selectivity at the glomerular capillary wall that lead to an inability to restrict the urinary loss of protein.

Detailed description

Childhood nephrotic syndrome is the most frequent glomerular disease that presents during childhood,primarily owing to a disturbed immune function.This disease is characterized by alterations in selectivity at the glomerular capillary wall that lead to an inability to restrict the urinary loss of protein.The syndrome is characterized by the tetrad of nephrotic range proteinuria (\>40 mg/m2/hour), hypoalbuminemia (\<2.5 g/dl), generalized edema, and hyperlipidemia. It can be congenital or acquired.Currently,serum albumin, lipids, and proteinuria are the common diagnostic markers of childhood NS, but these markers may not accurately predict the outcome of individual patients because of the heterogeneity of the disease. Renal biopsy is more precise for establishing prognosis of renal outcome, but it has potential complications. Repeated monitoring is technically difficult, particularly for children. Therefore, there is still an urgent need to identify new non invasive diagnostic and prognostic biomarkers and new therapeutic targets for this disease.miRNA-30a expression in the serum of patients with nephrotic syndrome and analyzed the correlation between miRNA with largest over expression level and clinical features compared with healthy subjects.miRNA-30a expression level in drug resistant nephrotic syndrome patients was obviously higher than the drug sensitive patients and up-regulated most significantly in mesangial proliferative glomerulonephritis among different pathological types, while it decreased most obviously in glomerular lesions. miRNA-30a could be treated as the molecular marker in predict drug resistance, pathological type of nephrotic syndrome and follow up of resistant cases.

Interventions

DIAGNOSTIC_TEST‗Urine analysis ‗Urine protein quantification ‗Serum albumin ‗Lipid profile.Quantitation of miRNA -30a by Real-time polymerase chain reaction (Q-PCR) in peripheral blood.

Specific tests Quantitation of miRNA -30a by Real-time polymerase chain reaction (Q-PCR) in peripheral blood

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

-Nephrotic children aged from 2 to 18 that admitted to Pediatric Hospital.

Exclusion criteria

* Congenital or infantile nephrotic syndrome * Other kidney diseases * Abnormal kidney function test

Design outcomes

Primary

MeasureTime frameDescription
Percentage of patients with highly expressed serum miRNA30-a in resistant cases of childhood nephrotic syndrome.3 daysQuantitation of miRNA -30a by Real-time polymerase chain reaction (Q-PCR) in peripheral blood.

Contacts

Primary ContactHanan Omar Mohamed, Professor Doctor
hannahomer@yahoo.com01223971654
Backup ContactEman Mohammed Salaheldin, Lecturer
emansalah.eldin@yahoo.com01028030966

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026